Meta-analyses of moving targets

Colin Berry^{1

2}

Affiliations

¹ British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, UK.
² Golden Jubilee National Hospital, Clydebank, United Kingdom.

Editorial

Colin Berry. Eur Heart J. 2021.

. 2021 Jul 15;42(27):2655-2656.

doi: 10.1093/eurheartj/ehab359.

Colin Berry^{1

2}

¹ British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, UK.
² Golden Jubilee National Hospital, Clydebank, United Kingdom.

No abstract available

Comment in

Strengths and limitations of meta-analyses.
Berry C. Berry C. Eur Heart J. 2022 Feb 12;43(7):698. doi: 10.1093/eurheartj/ehab682. Eur Heart J. 2022. PMID: 34725679 Free PMC article. No abstract available.
Reporting data from meta-analysis: snapshot of a moving target.
Ahmad Y, Howard JP, Madhavan MV, Bangalore S, Stone GW. Ahmad Y, et al. Eur Heart J. 2022 Feb 12;43(7):699-700. doi: 10.1093/eurheartj/ehab681. Eur Heart J. 2022. PMID: 34725703 Free PMC article. No abstract available.

Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials.
Madhavan MV, Howard JP, Naqvi A, Ben-Yehuda O, Redfors B, Prasad M, Shahim B, Leon MB, Bangalore S, Stone GW, Ahmad Y. Madhavan MV, et al. Eur Heart J. 2021 Jul 15;42(27):2643-2654. doi: 10.1093/eurheartj/ehab280. Eur Heart J. 2021. PMID: 34002202 Free PMC article.

1. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019;40:87–165. - PubMed
1. Crea F, Bairey Merz CN, Beltrame JF, Berry C, Camici PG, Kaski JC, Ong P, Pepine CJ, Sechtem U, Shimokawa H. Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronaryrevascularization. Eur Heart J 2019;40:2455–2462. - PubMed
1. Bangalore S, Toklu B, Patel N, Feit F, Stone GW. Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease. Circulation 2018;138:2216–2226. - PubMed
1. Madhavan MV, Howard JP, Naqvi A, Ben-Yehuda O, Redfors B, Prasad M, Shahim B, Leon MB, Bangalore S, Stone GW, Ahmad Y. Long-term Follow-up after Ultrathin versus Conventional Second-Generation Drug eluting Stents: systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Heart J 2021;doi:10.1093/eurheartj/ehab280. - PMC - PubMed
1. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264–269. - PubMed